Novartis India Q1FY23 net profit jumps to Rs. 52.38 crores

Novartis India Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 147.44 crores during the period ended June 30, 2022 as compared to Rs. 112.63 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 52.38 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -23.37 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 21.21 for the period ended June 30, 2022 as compared to Rs. -9.47 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 147.44 crs	₹112.63 crs	30.91%
Net Profit	₹52.38 crs	₹-23.37 crs	324.13%
EPS	₹21.21	₹-9.47	323.97%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 147.44 crores during the period ended June 30, 2022 as compared to Rs.104.57 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.52.38 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.6.28 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.21.21 for the period ended June 30, 2022 as compared to Rs.2.55 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 147.44 crs	₹104.57 crs	41.00%
Net Profit	₹52.38 crs	₹6.28 crs	734.08%
EPS	₹21.21	₹2.55	731.76%

Shares of Novartis India Limited was last trading in BSE at Rs. 651.45 as compared to the previous close of Rs. 657.80. The total number of shares traded during the day was 636 in over 122 trades.

The stock hit an intraday high of Rs. 659.95 and intraday low of 647.50. The net turnover during the day was Rs. 415670.00.

Source : Equity Bulls

Keywords

NovartisIndia Q1FY23 ResultUpdate